Paid Clinical Trials in Foxborough, MA
As of August 2026, 35 paid clinical trials are recruiting in Foxborough, Massachusetts. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Foxborough offers studies at sites including Dana-Farber Cancer Institute at Foxborough for conditions such as Breast Cancer, Alcohol Use Disorder, Alzheimer Disease, Generalized Myasthenia Gravis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Foxborough
Trials by drug in Foxborough
Filter results
35 clinical trials
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Brenipatide in Participants With Alcohol Use Disorder
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Losartan to Improve Outcomes After Multi-ligament Knee Injury
A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
Blood Flow Restriction Training After Patellar INStability
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Top Research Study Locations in Foxborough
Researchers run research studies in Foxborough, MA at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dana-Farber Cancer Institute at Foxborough | Stage IIIB Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 10 |
| K2 Medical Research - Foxborough | Alcohol Use Disorder, Amyloid, Cognitive Dysfunction | 4 |
| Neurology Center of New England | Amyloid, Cognitive Dysfunction, Generalized Myasthenia Gravis | 3 |
| Dana-Farber Brigham Cancer Center - Foxborough | Breast Cancer, Colonic Diseases, Colorectal Neoplasms | 2 |
| Brigham and Women's Foxborough | Lumbar Spinal Stenosis | 1 |
| Brigham and Women's-Mass General Health Care Center | Lumbar Spinal Stenosis | 1 |
| Brigham and Womens/Mass General Health Care Center at Foxborough | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Center for Sports Performance and Research | Knee Injuries, Leg Injury, Patellar Dislocation | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| DFCI @ Foxborough | Breast Cancer, PD-L1 Negative, Triple Negative Breast Cancer | 1 |
| Dana Farber Cancer Institute at Foxborough | Breast Cancer | 1 |
| Dana-Farber Brigham Cancer Center Foxborough | Metastatic Breast Cancer | 1 |
| Dana-Farber Cancer Institute @Foxborough | Triple Negative Breast Cancer | 1 |
| Foxboro Sports Medicine Clinic | Knee Injuries, Leg Injury, Patellar Dislocation | 1 |
| K2 Medical Research | Agitation, Alzheimer Disease | 1 |
| Local Institution - 1663 | Alzheimer Disease | 1 |
| Mass General Brigham | Multi-ligament Knee Injury | 1 |
| Neuro Institute of New England P C | Secondary Progressive Multiple Sclerosis (SPMS) | 1 |
| Neurology Center of NE,PC - Neurology | Chronic Migraine, Episodic Migraine | 1 |
| Neurology Center of New England P.C. | Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis | 1 |
| Neurology Center of New England PC | Relapsing Multiple Sclerosis | 1 |
| TG Therapeutics Investigational Trial Site | Relapsing Multiple Sclerosis | 1 |
Active & Upcoming Studies in Foxborough (2026)
Recruiting trials in Foxborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 · Phase 3 · Summit Therapeutics
Neurology & pain (8 active studies)
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis · Phase 3 · Novartis Pharmaceuticals
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) · Phase 3 · Bristol-Myers Squibb
Common conditions studied in Foxborough
- Breast Cancer (4 active studies)
- Alcohol Use Disorder (2 active studies)
- Alzheimer Disease (2 active studies)
- Generalized Myasthenia Gravis (2 active studies)
- Relapsing Multiple Sclerosis (2 active studies)
- Stage IIIB Lung Cancer AJCC v8 (2 active studies)
Leading research sponsors in Foxborough
- Alliance for Clinical Trials in Oncology
- Eli Lilly and Company
- Dana-Farber Cancer Institute
- National Cancer Institute (NCI)
- Celgene
Frequently asked questions
How many paid clinical trials are currently recruiting in Foxborough?
There are approximately 35 recruiting clinical trials in Foxborough, Massachusetts listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Foxborough pay participants?
Most recruiting trials in Foxborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Foxborough?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Foxborough?
The most common conditions under active study in Foxborough include Breast Cancer (4), Alcohol Use Disorder (2), Alzheimer Disease (2), Generalized Myasthenia Gravis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Foxborough?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Foxborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Foxborough?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Foxborough?
Recruiting research sites in Foxborough include Dana-Farber Cancer Institute at Foxborough, K2 Medical Research - Foxborough, Neurology Center of New England, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Foxborough right now?
The largest active categories in Foxborough are Cancer & tumors (17), Neurology & pain (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.